A Drug Content, Stability Analysis, and Qualitative Assessment of Pharmacists' Opinions of Two Exemplar Extemporaneous Formulations.
amlodipine
community pharmacist
extemporaneously compounding
omeprazole
unlicensed
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
06 Jul 2020
06 Jul 2020
Historique:
received:
15
06
2020
revised:
03
07
2020
accepted:
05
07
2020
entrez:
10
7
2020
pubmed:
10
7
2020
medline:
16
3
2021
Statut:
epublish
Résumé
Despite a decline in the number of active pharmaceutical ingredients prepared extemporaneously using proprietary products, there remains a need for such products in the community (for example, liquid medicines for paediatrics which may be otherwise commercially unavailable). A lack of experience and quality assurance systems may have diminished pharmacist's confidence in the extemporaneous preparation process; therefore, pharmacists were asked to prepare two proprietary products, omeprazole and amlodipine. The resulting products were characterised in terms of variability in drug quantity, stability, particle size and antimicrobial properties. Furthermore, a self-administered questionnaire was used to assess 10 pharmacists' opinions on the perceived complexity of the extemporaneous compounding process and their overall confidence in the final extemporaneously compounded products. Drug content studies revealed that 88.5% and 98.0% of the desired drug content was obtained for omeprazole and amlodipine, respectively. Antimicrobial properties were maintained for both drugs, however variability in particle size, particularly for amlodipine, was evident between formulations. While pharmacists who partook in the study had some or high confidence in the final products, they reported difficulty formulating the suspensions. Findings from this study provide insight into pharmacists' views on two extemporaneously prepared products and highlight the variability obtained in preparations prepared by different pharmacists.
Identifiants
pubmed: 32640709
pii: molecules25133078
doi: 10.3390/molecules25133078
pmc: PMC7412138
pii:
doi:
Substances chimiques
Anti-Infective Agents
0
Suspensions
0
Amlodipine
1J444QC288
Omeprazole
KG60484QX9
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Int J Pharm Pract. 2009 Feb;17(1):67-71
pubmed: 20218032
Pediatrics. 2011 May;127(5):925-35
pubmed: 21464183
Med Law Rev. 2014 Winter;22(1):87-108
pubmed: 24327399